These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19706149)

  • 21. [Epidemiology in inflammatory bowel disease in five areas of Asturias. Spain].
    Saro Gismera C; Riestra Menéndez S; Sánchez Fernández R; Milla Crespo A; Lacort Fernández M; Argüelles Fernández G; Chobak Z; Florido Mancheño JI; Antón Magarzo JL; Altadill Arregui A; Vizoso F; Pineda García E; Fernández de Ocariz Archs E; Albert Colomer J; García Pérez J; López Rivas L; Lombraña JL
    An Med Interna; 2003 May; 20(5):232-8. PubMed ID: 12831296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
    Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
    Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacologic therapy of Crohn's disease and ulcerative colitis].
    Banai J
    Orv Hetil; 2000 May; 141(22):1171-7. PubMed ID: 10853345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory bowel disease. An epidemiological and genetic study.
    Monsén U
    Acta Chir Scand Suppl; 1990; 559():1-42. PubMed ID: 2092567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study.
    Chow DK; Sung JJ; Tsoi KK; Wong VW; Wu JC; Leong RW; Chan FK
    Aliment Pharmacol Ther; 2009 Apr; 29(8):843-54. PubMed ID: 19154567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA
    Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and economic outcomes in a population-based European cohort of 948 ulcerative colitis and Crohn's disease patients by Markov analysis.
    Odes S; Vardi H; Friger M; Esser D; Wolters F; Moum B; Waters H; Elkjaer M; Bernklev T; Tsianos E; O'Morain C; Stockbrügger R; Munkholm P; Langholz E
    Aliment Pharmacol Ther; 2010 Apr; 31(7):735-44. PubMed ID: 20047578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of inflammatory bowel disease in patients with airways disease.
    Raj AA; Birring SS; Green R; Grant A; de Caestecker J; Pavord ID
    Respir Med; 2008 May; 102(5):780-5. PubMed ID: 18321696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002.
    Herrinton LJ; Liu L; Lewis JD; Griffin PM; Allison J
    Am J Gastroenterol; 2008 Aug; 103(8):1998-2006. PubMed ID: 18796097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
    Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF
    Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adherence to medical treatment in inflammatory bowel disease patients.
    Zelante A; De Giorgi A; Borgoni R; Trevisani L; Gallerani M
    Minerva Gastroenterol Dietol; 2014 Dec; 60(4):269-74. PubMed ID: 25384805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacotherapy in patients with ulcerative colitis].
    Scherer M; Hardt J; Blozik E; Preiss JC; Bokemeyer B; Hüppe A; Raspe H
    Z Gastroenterol; 2011 Jul; 49(7):820-6. PubMed ID: 21766260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study.
    van der Zee HH; van der Woude CJ; Florencia EF; Prens EP
    Br J Dermatol; 2010 Jan; 162(1):195-7. PubMed ID: 19681876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An investigation of medication adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis, using self-report and urinary drug excretion measurements.
    Moshkovska T; Stone MA; Clatworthy J; Smith RM; Bankart J; Baker R; Wang J; Horne R; Mayberry JF
    Aliment Pharmacol Ther; 2009 Dec; 30(11-12):1118-27. PubMed ID: 19785623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors of work disability in patients with inflammatory bowel disease--a Dutch nationwide web-based survey: work disability in inflammatory bowel disease.
    van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B; ;
    J Crohns Colitis; 2014 Jul; 8(7):590-7. PubMed ID: 24351733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease.
    Spekhorst LM; Oldenburg B; van Bodegraven AA; de Jong DJ; Imhann F; van der Meulen-de Jong AE; Pierik MJ; van der Woude JC; Dijkstra G; D'Haens G; Löwenberg M; Weersma RK; Festen EAM;
    World J Gastroenterol; 2017 Dec; 23(46):8182-8192. PubMed ID: 29290654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.